XML 22 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect of change in accounting principle
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting principle
Total United Natural Foods, Inc. Stockholders’ Equity
Total United Natural Foods, Inc. Stockholders’ Equity
Cumulative effect of change in accounting principle
Noncontrolling Interests
Beginning balance (in shares) at Aug. 03, 2019     53,501 615              
Beginning balance at Aug. 03, 2019 $ 1,504,305 $ (2,613) $ 535 $ (24,231) $ 530,801 $ (108,953) $ 1,108,890 $ (2,613) $ 1,507,042 $ (2,613) $ (2,737)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     464                
Restricted stock vestings (1,015)   $ (5)   (1,020)       (1,015)    
Share-based compensation 15,088       15,088       15,088    
Other comprehensive (loss) income (42,692)         (42,692)     (42,692)    
Distributions to noncontrolling interests (2,525)                   (2,525)
Proceeds from issuance of common stock, net (in shares)     1,327                
Proceeds from issuance of common stock, net 13,882   $ 13   13,869       13,882    
Net income (323,099)           (326,506)   (326,506)   3,407
Ending balance (in shares) at May. 02, 2020     55,292 615              
Ending balance at May. 02, 2020 1,161,331   $ 553 $ (24,231) 558,738 (151,645) 779,771   1,163,186   (1,855)
Beginning balance (in shares) at Feb. 01, 2020     54,175 615              
Beginning balance at Feb. 01, 2020 1,092,465   $ 542 $ (24,231) 535,900 (108,420) 691,640   1,095,431   (2,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     21                
Restricted stock vestings (143)       (143)       (143)    
Share-based compensation 11,137       11,137       11,137    
Other comprehensive (loss) income (43,225)         (43,225)     (43,225)    
Distributions to noncontrolling interests (1,127)                   (1,127)
Proceeds from issuance of common stock, net (in shares)     1,096                
Proceeds from issuance of common stock, net 11,855   $ 11   11,844       11,855    
Net income 90,369           88,131   88,131   2,238
Ending balance (in shares) at May. 02, 2020     55,292 615              
Ending balance at May. 02, 2020 $ 1,161,331   $ 553 $ (24,231) 558,738 (151,645) 779,771   1,163,186   (1,855)
Beginning balance (in shares) at Aug. 01, 2020 54,691   55,306 615              
Beginning balance at Aug. 01, 2020 $ 1,142,258 $ (9,237) $ 553 $ (24,231) 568,736 (237,946) 837,633 $ (9,237) 1,144,745 $ (9,237) (2,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     1,606                
Restricted stock vestings (13,449)   $ (17)   (13,466)       (13,449)    
Share-based compensation 32,847       32,847       32,847    
Other comprehensive (loss) income 40,854         40,854     40,854    
Distributions to noncontrolling interests (3,082)                   (3,082)
Proceeds from issuance of common stock, net (in shares)     44                
Proceeds from issuance of common stock, net 721       721       721    
Acquisition of noncontrolling interests (691)       (514)       (514)   (177)
Net income $ 110,841           106,475   106,475   4,366
Ending balance (in shares) at May. 01, 2021 56,341   56,956 615              
Ending balance at May. 01, 2021 $ 1,301,062   $ 570 $ (24,231) 588,324 (197,092) 934,871   1,302,442   (1,380)
Beginning balance (in shares) at Jan. 30, 2021     56,763 615              
Beginning balance at Jan. 30, 2021 1,229,066   $ 568 $ (24,231) 581,096 (213,529) 886,313   1,230,217   (1,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Restricted stock vestings and stock option exercises (in shares)     163                
Restricted stock vestings (3,052)   $ (2)   (3,054)       (3,052)    
Share-based compensation 9,918       9,918       9,918    
Other comprehensive (loss) income 16,437         16,437     16,437    
Distributions to noncontrolling interests (1,622)                   (1,622)
Proceeds from issuance of common stock, net (in shares)     30                
Proceeds from issuance of common stock, net 514       514       514    
Acquisition of noncontrolling interests (151)       (150)       (150)   (1)
Net income $ 49,952           48,558   48,558   1,394
Ending balance (in shares) at May. 01, 2021 56,341   56,956 615              
Ending balance at May. 01, 2021 $ 1,301,062   $ 570 $ (24,231) $ 588,324 $ (197,092) $ 934,871   $ 1,302,442   $ (1,380)